Sustained SREBP-1-dependent lipogenesis as a key mediator of resistance to BRAF-targeted therapy
暂无分享，去创建一个
P. Agostinis | J. Marine | F. Rambow | J. J. van den Oord | J. Swinnen | R. Derua | E. Waelkens | D. Nittner | S. Fendt | A. Talebi | J. Dehairs | A. Rogiers | K. van den Eynde | F. Bosisio | F. Vanderhoydonc | K. Nys | M. V. Pérez | João A. G. Duarte | David Nittner